Browsing byAuthorMoon, Yujeong
Showing results 1 to 16 of 16
| Issue Date | Title | Author(s) |
|---|---|---|
| 2024-04 | Accurately Controlled Tumor Temperature with Silica-Coated Gold Nanorods for Optimal Immune Checkpoint Blockade Therapy | Yun, Wan Su; Yang, Wonseok; Shim, Man Kyu; Song, Sukyung; Choi, Jiwoong; Kim, Jeongrae; Kim, Jinseong; Moon, Yujeong; SeongHoon, Jo; Lim, Dong-Kwon; Kim, Kwangmeyung |
| 2023-10 | All-in-one glycol chitosan nanoparticles for co-delivery of doxorubicin and anti-PD-L1 peptide in cancer immunotherapy | Song, Sukyung; Shim, Man Kyu; Yang, Suah; Lee, Jaewan; Yun, Wan Su; Cho, Hanhee; Moon, Yujeong; Min, Jin Young; Han, Eun Hee; Yoon, Hong Yeol; Kim, Kwangmeyung |
| 2022-05 | Anti-PD-L1 peptide-conjugated prodrug nanoparticles for targeted cancer immunotherapy combining PD-L1 blockade with immunogenic cell death | Moon, Yujeong; Shim, Man Kyu; Choi, Jiwoong; Yang, Suah; Kim, Jinseong; Yun, Wan Su; Cho, Hanhee; Park, Jung Yeon; Kim, Yongju; Seong, Joon-Kyung; Kim, Kwangmeyung |
| 2024-03 | Cancer cell-specific and pro-apoptotic SMAC peptide-doxorubicin conjugated prodrug encapsulated aposomes for synergistic cancer immunotherapy | Kim, Jinseong; Shim, Man Kyu; Moon, Yujeong; Kim, Jeongrae; Cho, Hanhee; Yun, Wan Su; Shim, Nayeon; Seong, Joon-Kyung; Lee, Yonghyun; Lim, Dong-Kwon; Kim, Kwangmeyung |
| 2021-05 | Cancer-activated doxorubicin prodrug nanoparticles induce preferential immune response with minimal doxorubicin-related toxicity | Yang, Suah; Shim, Man Kyu; Kim, Woo Jun; Choi, Jiwoong; Nam, Gi-Hoon; Kim, Jeongrae; Kim, Jinseong; Moon, Yujeong; Kim, Han Young; Park, Jooho; Park, Yoon; Kim, In-San; Ryu, Ju Hee; Kim, Kwangmeyung |
| 2023-02 | Cancer-Specific Delivery of Proteolysis-Targeting Chimeras (PROTACs) and Their Application to Cancer Immunotherapy | Moon, Yujeong; Jeon, Seong Ik; Shim, Man Kyu; Kim, Kwangmeyung |
| 2020-12 | Cancer-specific drug-drug nanoparticles of pro-apoptotic and cathepsin B-cleavable peptide-conjugated doxorubicin for drug-resistant cancer therapy | Shim, Man Kyu; Moon, Yujeong; Yang, Suah; Kim, Jinseong; Cho, Hanhee; Lim, Seungho; Yoon, Hong Yeol; Seong, Joon-Kyung; Kim, Kwangmeyung |
| 2022-01 | Cathepsin B-Overexpressed Tumor Cell Activatable Albumin-Binding Doxorubicin Prodrug for Cancer-Targeted Therapy | Cho, Hanhee; Shim, Man Kyu; Yang, Suah; Song, Sukyung; Moon, Yujeong; Kim, Jinseong; Byun, Youngro; Ahn, Cheol-Hee; Kim, Kwangmeyung |
| 2021-02-10 | Combination of cancer-specific prodrug nanoparticle with Bcl-2 inhibitor to overcome acquired drug resistance | Kim, Jinseong; Shim, Man Kyu; Yang, Suah; Moon, Yujeong; Song, Sukyung; Choi, Jiwoong; Kim, Jeongrae; Kim, Kwangmeyung |
| 2020-12 | Doxorubicin-Loaded PLGA Nanoparticles for Cancer Therapy: Molecular Weight Effect of PLGA in Doxorubicin Release for Controlling Immunogenic Cell Death | Choi, Yongwhan; Yoon, Hong Yeol; Kim, Jeongrae; Yang, Suah; Lee, Jaewan; Choi, Ji Woong; Moon, Yujeong; Kim, Jinseong; Lim, Seungho; Shim, Man Kyu; Jeon, Sangmin; Kwon, Ick Chan; Kim, Kwangmeyung |
| 2022-10 | Implantable micro-scale LED device guided photodynamic therapy to potentiate antitumor immunity with mild visible light | Choi, Jiwoong; Lee, Il Seong; Lee, Ju Seung; Jeon, Sangmin; Yun, Wan Su; Yang, Suah; Moon, Yujeong; Kim, Jinseong; Kim, Jeongrae; Choy, Seunghwan; Jeong, Chanho; Shim, Man Kyu; Kim, Tae-Il; 김광명 |
| 2020-05 | In Situ One-Step Fluorescence Labeling Strategy of Exosomes via Bioorthogonal Click Chemistry for Real-Time Exosome Tracking In Vitro and In Vivo | Song, Sukyung; Shim, Man Kyu; Lim, Seungho; Moon, Yujeong; Yang, Suah; Kim, Jinseong; Hong, Yeonsun; Yoon, Hong Yeol; Kim, In-San; Hwang, Kwang Yeon; Kim, Kwangmeyung |
| 2022-10 | Preclinical development of carrier-free prodrug nanoparticles for enhanced antitumor therapeutic potential with less toxicity | Shim, Man Kyu; Yang, Suah; Park, Jooho; Yoon, Jun Sik; Kim, Jinseong; Moon, Yujeong; Shim, Nayeon; Jo, Mihee; Choi, Yongwhan; Kim, Kwang meyung |
| 2022-03 | Sustained and Long-Term Release of Doxorubicin from PLGA Nanoparticles for Eliciting Anti-Tumor Immune Responses | Kim, Jeongrae; Choi, Yongwhan; Yang, Suah; Lee, Jaewan; Choi, Jiwoong; Moon, Yujeong; Kim, Jinseong; Shim, Nayeon; Cho, Hanhee; Shim, Man Kyu; Jeon, Sangmin; Lim, Dong-Kwon; Yoon, Hong Yeol; Kim, Kwangmeyung |
| 2021-12 | The safe and effective intraperitoneal chemotherapy with cathepsin B-specific doxorubicin prodrug nanoparticles in ovarian cancer with peritoneal carcinomatosis | Kim, Jinseong; Shim, Man Kyu; Cho, Young-Jae; Jeon, Sangmin; Moon, Yujeong; Choi, Jiwoong; Kim, Jeongrae; Lee, Jaewan; Lee, Jeong-Won; Kim, Kwangmeyung |
| 2021-07-27 | Visible-Light-Triggered Prodrug Nanoparticles Combine Chemotherapy and Photodynamic Therapy to Potentiate Checkpoint Blockade Cancer Immunotherapy | Choi, Jiwoong; Shim, Man Kyu; Yang, Suah; Hwang, Hee Sook; Cho, Hanhee; Kim, Jeongrae; Yun, Wan Su; Moon, Yujeong; Kim, Jinseong; Yoon, Hong Yeol; Kim, Kwangmeyung |
KIST 리포지터리는 국립중앙도서관 OAK 보급사업으로 구축되었습니다.